Through its wide range of research and development partnerships at home and abroad, GC Pharma is working hard to create a brighter future.

In-licensing

GC Pharma (formerly known as Green Cross Corporation) has been maximizing the efficacy of its own research institute, and is now realizing open innovation through the creation of R&D synergy based on its dynamic interactions with academia, innovative biotech companies, and leading global pharmaceutical companies.
GC Pharma continues to secure technical competitiveness in the global biotechnology market and reinforce its R&D pipelines by forming domestic and international partnerships.

have experience and infrastructure related to the development of biological products, including vaccines, plasma derivatives, and recombinant proteins

have strong commitments to the development of in-licensed products

have experience in and capabilities that can be applied to commercializing in-licensed products

Out-licensing

Collaboration with GC Pharma, which has accumulated comprehensive experience in the development of biological drugs, including vaccines, plasma derivatives, and recombinant proteins, gives our partners the opportunity to benefit from our highly experienced research, development, and medical teams, who possess a wide range of scientific, regulatory, clinical, and business capabilities. Not limited to drug development, GC Pharma also offers established sales and marketing capabilities across Korean and overseas markets through it diverse distribution channels.

GC Pharma is actively exploring partnership opportunities in relation to marked products, platform technologies, and drug candidates under development that are in line with GC Pharma’ strategic focus.